Regorafenib (Stivarga)

regorafenib · Bayer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Regorafenib (Stivarga), covering 2017-08-01 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib [Phase 2]